Investigating the acceptability of a single dose of Strepsils Strawberry sugar free and Orange colour free with Vitamin C lozenges in children

ISRCTN ISRCTN34958871
DOI https://doi.org/10.1186/ISRCTN34958871
Secondary identifying numbers TH1016
Submission date
30/08/2012
Registration date
05/09/2012
Last edited
29/08/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
In 2006, the European Agency for the Evaluation of Medicinal Products (EMEA) stated that the main consideration when developing medications for children should be its acceptability to the child. It described the difficulty experienced by children in recognising tastes and suggested that their ability to recognise flavour may also be affected by the concentration of the flavour and the appearance of the medication. The purpose of this taste testing study is to investigate the acceptability of the flavours of Strepsils strawberry sugar free and orange colour free with vitamin C in children aged six to twelve years old.

Who can participate?
Healthy, male and female children aged between 6 and 12 years.

What does the study involve?
Participants will receive a single Strepsils strawberry sugar free lozenge followed at least 15 minutes later by a single Strepsils orange colour free with vitamin C lozenge. All participants will taste the strawberry flavoured lozenge first, followed by the orange flavoured lozenge. Each participant will suck the lozenge for 1 minute and will be instructed not to chew, crunch or swallow the lozenge and to spit it out after 1 minute. After this they will be asked a series of questions on a questionnaire.

What are the possible benefits and risks of participating?
There is no anticipated benefit for the participants. The safety of Strepsils lozenges has been well established over many years of use as an over the counter product and the potential risks to subjects are considered to be low.

Where is the study run from?
Aspect Clinical, Ledbury.

When is the study starting and how long is it expected to run for?
The study ran from November to December 2010.

Who is funding the study?
Reckitt Benckiser, UK.

Who is the main contact?
Emma Field
Emma.Field@ReckittBenckiser.com

Contact information

Dr Alex Thompson
Scientific

Hill House
4A Bye Street
Ledbury
HR8 2AA
United Kingdom

Study information

Study designOpen label single dose taste test
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleAn open label taste testing study in healthy children to investigate the acceptability of a single dose of Strepsils Strawberry sugar free and Orange colour free with Vitamin C lozenges
Study hypothesisTo assess the taste acceptability in children, aged between 6 and 12 years, of two flavour vairants of an AMC 0.5mg and DCBA 1.2mg sore throat lozenge (strawberry and orange)
Ethics approval(s)Reading Independent Ethics Committee
ConditionHealthy subjects
InterventionAMC 0.5mg and DCBA 1.2mg sore throat lozenge
Intervention typeOther
Primary outcome measureThe percentage of children that rated each lozenge above four on the hedonic facial scale.
Secondary outcome measuresDescriptive summary statistics (mean, standard deviation, median, min, max) and the frequencies (with percentages) of the hedonic facial scale scores for each lozenge were presented.
Overall study start date17/11/2010
Overall study end date10/12/2010

Eligibility

Participant type(s)Healthy volunteer
Age groupChild
Lower age limit6 Years
Upper age limit12 Years
SexBoth
Target number of participants102
Participant inclusion criteria1. Aged 6 to 12 years inclusive
2. Male or female
3. Healthy volunteers
Participant exclusion criteria1. A history of hereditary fructose intolerance
2. A history of sensitivity to an analgesic medication, its ingredients or related products, or any previous history of allergy or known intolerance to dichlorobenzyl alcohol, amylmetacresol, any colouring, flavouring, preservative, sweetener or surfactant. (A list of all constituents that could possibly have given rise to allergy is given in Appendix III of the protocol)
3. A history of hepatic or renal impairment, cardiac disease or high blood pressure
4. A history of asthma
5. A history of peptic or duodenal ulcers, gastro-intestinal bleeding or frequent dyspepsia, e.g. heartburn or indigestion
6. A respiratory infection or any other condition that could have affected subjects’ perception of taste
7. More than two siblings already participating in the trial
8. Previous completion of the study
9. Participation in a taste testing study within three days of the screening visit
10. Participation in a clinical trial involving consumption of an investigational medicinal product within one month of the screening visit
11. Inability in the opinion of the Medical Investigator to comply fully with the study requirements
12. Use of prescription medications within seven days of the taste testing day
13. Use of analgesic or anaesthetic medication on the day of taste testing
14. Consumption of food or drink that was likely to have affected the subject’s ability to taste the product (e.g. highly spiced meals, mint or menthol based products) on the day of taste testing
15. Use of non-prescription medication in the four hours before taste testing
16. Current mouth ulcer
17. Any dental work on the day of taste testing
Recruitment start date17/11/2010
Recruitment end date10/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Hill House
Ledbury
HR8 2AA
United Kingdom

Sponsor information

Reckitt Benckiser Healthcare (UK)
Industry

Dansom Lane
Hull
HU8 7DS
United Kingdom

Website http://www.rb.com/
ROR logo "ROR" https://ror.org/01g87hr29

Funders

Funder type

Industry

Reckitt Benckiser Healthcare (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2013 Yes No